Indication
Recurrent Glioblastoma with EGFR Alterations
The Recurrent Glioblastoma with EGFR Alterations pipeline: 1 tracked drug.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Recurrent Glioblastoma with EGFR Alterations, so this list is not complete.
1 preclinical / unstaged
Market size not yet sourced. How markets are sized ↗